Det tredje forsøg vurderer den gavnlige virkning af yderligere 12 ugers behandling med CHAMPIX for at fastholderygeophør.
Maintenance of Abstinence Study The third study assessed the benefit of an additional 12 weeks of CHAMPIX therapy on the maintenance of abstinence.